Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.06
Delayed Data
As of Dec 02
 +0.09 / +2.27%
Today’s Change
3.78
Today|||52-Week Range
10.95
-62.37%
Year-to-Date

Today’s Trading

Previous close3.97
Today’s open3.97
Day’s range3.91 - 4.12
Volume948,503
Average volume (3 months)1,847,879
Market cap$542.6M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+94.29%
Earnings growth (this year)-1,408.61%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales20.49
Price/Book1.21

Competitors

 Today’s
change
Today’s
% change
--Pharmstandard PAO-0.59-13.09%
RETAReata Pharmaceutical...+0.87+3.47%
SCLNSciClone Pharmaceuti...-0.05-0.49%
FLXNFlexion Therapeutics...+0.96+5.80%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$66.1M
Annual profit (last year)-$5.0M
Net profit margin-7.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Executive VP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts


Search for Jobs